Business
Board Change
Board Change.
About this update from Ixico Plc
[{"type":"text","content":"\n RNS Number : 0593I Phytopharm PLC 13 November 2008 \n \n13 November 2008\nPhytopharm plc\n\nBoard Changes\n\nGODMANCHESTER, Cambridgeshire, U.K.- The Board of Phytopharm plc (PYM: London Stock Exchange) ('Phytopharm' or the 'Company') today announces that the Company has received notice of termination of employment contract from Daryl Rees, Chief Executive Officer, and Piers Morgan, Chief Financial Officer. They cease to be Directors of the Company with immediate effect. \n\nA further announcement in respect of the Company's future direction and management will be made in due course.\n\nThe Company's preliminary results will be announced on 27 November 2008 as planned.\n\n -Ends-\n\nNotes to Editors\nPhytopharm plc\nPhytopharm is a pharmaceutical development and functional food company. Our products are developed from medicinal plants, thereby reducing the development risk, cost and time to market. As a virtual company, Phytopharm's business model is centred on a lean cash burn with all laboratory, manufacturing and clinical work out-sourced to specialists, while core competencies such as strategy and management are maintained in-house. Close collaboration with charitable organisations enhances our interaction with worldwide specialists and accelerates our development programmes increasing their value.\n\n\n\n\n\n\nEnquiries\nPhytopharm plc\nAlistair Taylor, Chairman\nSandy Morrison, Non-Executive Director\n+44 1480 437 697\n\n\n\n\n\nU.K. Investor Relations\nFD\nDavid Yates\nJohn Dineen\n+44 207 831 3113\n\n\n\n\n\nFor further information about Phytopharm please see our website at http://www.phytopharm.com\n\nThis information is provided by RNSThe company news service from the London Stock Exchange END BOABIBDBRBBGGID \n ","length":4096,"tagName":"div"}]